NASDAQ: CYABCyabra Inc Stock
$0.58+0.02 (+3.57%)
Updated Jun 8, 2026
Shares of software companies are... find out Why CYAB Price Moved with a free WallStreetZen account
Why Price MovedCYAB Price
$0.58
Fair Value Price
N/A
Market Cap
$8.10M
52 Week Low
$0.50
52 Week High
$14.91
P/E
-0.03x
P/B
-0.67x
P/S
0.9x
PEG
N/A
Dividend Yield
N/A
Revenue
$7.12M
Earnings
-$23.14M
Gross Margin
85.1%
Operating Margin
-313.88%
Profit Margin
-324.9%
Debt to Equity
-1.38
Operating Cash Flow
-$10M
Beta
-0.09
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CYAB Overview
Cyabra, Inc. focuses on scrutinizing data for authenticity. The company provides a sophisticated software platform specifically designed to pinpoint and immediately counter misinformation. Furthermore, its capabilities extend to uncovering material generated by artificial intelligence, identifying automated bot networks, exposing fake online identities, and detecting manipulated deepfake content. This firm was established in July 2017 by co-founders Dan Brahmy, Yossef Daar, and Ido Shraga, and its main office is situated in Tel Aviv, Israel.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CYAB's potential to beat the market
FStrong Sell
- Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Software Infrastructure
Industry Rating
B
CYAB
Ranked#121 of 127
Ranked#121 of 127
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $23.15 | A | |
| $9.06 | A | |
| $4.81 | A |
Be the first to know about important CYAB news, forecast changes, insider trades & much more!
CYAB News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CYAB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CYAB is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CYAB is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
CYAB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more CYAB due diligence checks available for Premium users.
Valuation
CYAB fair value
Fair Value of CYAB stock based on Discounted Cash Flow (DCF)
Price
$0.58
Fair Value
-$2.75
Undervalued by
121.12%
CYAB is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CYAB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.03x
Industry
-194.48x
Market
14.72x
CYAB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.67x
Industry
8.15x
CYAB's financial health
Profit margin
Revenue
$1.4M
Net Income
-$10.8M
Profit Margin
-761.1%
CYAB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CYAB's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.5M
Liabilities
$16.6M
Debt to equity
-1.38
CYAB's short-term liabilities ($16.37M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CYAB's short-term assets ($3.77M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CYAB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CYAB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.6M
Investing
-$5.0k
Financing
$5.6M
CYAB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
CYAB vs Software Infrastructure Stocks
Cyabra Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.